Search

Author/Creator Rispo, A

11. P387 Different rate of transmural remission between first and second line of biologic treatment in Crohn's disease. (30th January 2023)

Authors:
De Sire, R; Rispo, A; Caiazzo, A; Testa, A; Nardone, O M; Guarino, A D; Olmo, O; Calabrese, G; Fierro, G; Toro, B; Cantisani, N M; Ferrante, M; La Mantia, A; D'Alessandro, E; Castiglione, F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i520
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. P522 Kono-S anastomosis reduces endoscopic and surgical post-operative recurrence in Crohn's disease. The SuPREMe-CD Trial Update. (30th January 2023)

Authors:
Luglio, G; Rispo, A; Tropeano, F P; Giglio, M C; Cricrì, M; Imperatore, N; De Sire, R; Guarino, A D; Bucci, L; Castiglione, F; De Palma, G D
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i650
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. P589 Effectiveness of partial enteral nutrition to treat adults with Crohn's Disease who lost response to biological therapy. (30th January 2023)

Authors:
Nardone, O M; Calabrese, G; Alfonsi, L; Rispo, A; La Mantia, A; Fierro, G; Ferrante, M; Testa, A; Guarino, A D; D'Alessandro, E; Pasanisi, F; Castiglione, F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i717
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. P605 Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study. (30th January 2023)

Authors:
Resál, T; Bacsur, P; Bor, R; Bálint, A; Katsanos, K; Michalopoylos, G; Ribaldone, D G; Attauabi, M; Mirabella, Z; Yanai, H; Bezzio, C; Castiglione, F; Bar-Gil Shitrit, A; Pugliese, D; Lakatos, P L; Savarino, E; Lukáš, M; Franko, M; Chashkova, E; Molander, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i732
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. P690 Comparative efficacy of vedolizumab and adalimumab as second-line therapy in ulcerative colitis patients previously treated with infliximab. (25th January 2019)

Authors:
Favale, A; Onali, S; Caprioli, F; Pugliese, D; Armuzzi, A; Macaluso, F S; Orlando, A; Viola, A; Fries, W; Mocci, G; Chicco, F; Usai, P; Rispo, A; Castiglione, F; Calabrese, E; Biancone, L; Monteleone, G; Fantini, M C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗